Table 1 Characteristics of included studies
Author (year) (reference number) | Country | Sample size | Infectious disease | Prevalence |
|---|---|---|---|---|
Klinkenberg et al. (2003) [2] | USA | 172 | HIV | Overall 6.2% (n/N = 11/172) Men 6.72% (n/N = 9/134) Women 5.26 (n/N = 2/38) |
Hung et al. (2012) [7] | China | 590 | HBV and HCV | Overall HBV 10.4% (n/N = 59/590) HBV men 14.4% (n/N = 43/299) HBV women 7.50% (n/N = 16/212) Overall HCV 1.9% (n/N = 11/588) HCV men 2.6% (n/N = 9/337) HCV women 0.8% (n/N = 2/240) |
Tharyan et al. (2003) [29] | India | 1160 | HIV | Overall 1.34% (n/N = 12/1160) Men 1.7 (11/663) Women 0.2 (1/497) |
Singh et al. (2014) [8] | USA | 206 | HIV | Overall B29.1% (n/N = 60/206) Men 20.34 (n/N = 24/118) Women 40.1% (n/N = 36/88) |
Kilbourne et al. (2004) [22] | USA | 4310 | HCV | Overall 5.9% (n/N = 252/4310) Men 6.23 (n/N = 242/3879) Women 2.33% (n/N = 10/431) |
HIV | Overall 0.8% (n/N = 35/4310) Men 0.88 (n/N = 34/3879) Women 0.23% (n/N = 1/431) | |||
Siberstein et al. (2017) [22] | USA | 117 | HIV | Overall 23% (n/N = 27/117) Men 23.53% (n/N = 24/102) Women 20% (n/N = 3/15) |
Cournos et al. (1991) [24] | USA | 962 | HIV | Overall 5.2% (n/N = 50/962) Men 5.2% (n/N = 29/563) Women 5.3% (n/N = 21/399) |
Stanley et al. (2016) [11] | Lebanon | 755 | HIV | Overall 3% (n/N = 23/755) Men 3.1% (n/N = 16/512) Women 2.9% (n/N = 7/243) |
HBV and HCV | HCV Overall 14% (n/N = 109/755) Men 17.58 (n/N = 90/512) Women 7.8% (n/N = 19/243) Overall HBV 19% (n/N = 141/755) | |||
Butterfield et al. (2003) [14] | USA | 777 | HCV | Overall 16.1% (n/N = 122/777) Men 19.8% (n/N = 98/526) Women 9.8% (n/N = 24/251) |
Pamela et al. (2017) [13] | South Africa | 151 | HIV | Overall 26.5 (n/N = 40/151) Men 19.7% (n/N = 15/76) Women 33.3% (n/N = 25/75) |
Maling et al. (2011) [27] | Uganda | 622 | HIV | Overall 18.4% (n/N = 50/272) Men 9.6% (n/N = 15/156) Women 30.2% (n/N = 35/116) |
Lumberg et al. (2014) [28] | Uganda | 602 | HIV | Overall 11.3% (n/N = 68/602) Men 7.3% (n/N = 19/259) Women 14.3% (n/N = 49/343) |
Nardo Di (1995) [10] | Italy | 206 | HBV and HCV | Overall HBV 47.5% (n/N = 97/206) HBV men 51.5% (n/N = 69/135) HBV women 39.44% (n/N = 28/71) Overall HCV 10.1% (n/N = 22/206) HCV men 8.9% (n/N = 12/135) HCV women 14.1% (n/N = 10/71) |
Esquivel et al. (2005) [30] | Mexico | 99 | HBV | Overall 12.12% (n/N = 12/99) Men 13.04% (n/N = 9/69) Women 10% (n/N = 3/30) |
Said et al. (2001) [9] | Jordan | 188 | HBV | Overall 7.45% (n/N = 14/188) Men 43% (n/N = 10/106) Women 4.88% (n/N = 4/82) |
Empfield et al. (1993) [21] | USA | 203 | HIV | Overall 6.4% (n/N = 13/203) Men 6.5% (n/N = 10/146) Women 5.3% (n/N = 3/57) |
Susser et al. (2015) [25] | USA | 62 | HIV | Men 19.4% (n/N = 12/62) |
Stewart et al. (1994) [26] | USA | 533 | HIV | Overall 5.85% (n/N = 31/530) Men 5% (n/N = 17/339) Women 7.3% (n/N = 14/191) |